Skip to Content

NIOX Group PLC NIOX

Morningstar Rating
GBX 67.60 −0.40 (0.59%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

NIOX is trading at a 67% premium.
Price
GBP 67.38
Fair Value
GBP 39.74
Uncertainty
High
1-Star Price
GBP 96.88
5-Star Price
GBP 36.57
Economic Moat
Pxw
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if NIOX is a good fit for your portfolio.

Trading Information

Previous Close Price
GBX 68.00
Day Range
GBX 66.2068.87
52-Week Range
GBX 54.0075.60
Bid/Ask
GBX 0.00 / GBX 0.00
Market Cap
GBX 28.67 Bil
Volume/Avg
3.6 Mil / 1.1 Mil

Key Statistics

Price/Earnings (Normalized)
18.18
Price/Sales
8.25
Dividend Yield (Trailing)
1.48%
Dividend Yield (Forward)
1.48%
Total Yield
1.51%

Company Profile

NIOX Group PLC is a medical device company that develops a range of therapies for asthma, chronic obstructive pulmonary disease, and allergy. The company has a single operating segment: NIOX. The NIOX segment relates to the portfolio of products used to improve asthma diagnosis and management by measuring fractional exhaled nitric oxide (FeNO). Geographically, it derives a majority of its revenue from the Asia Pacific and also has a presence in the European Union, the United States, the United Kingdom, and the Rest of the world.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Growth
Total Number of Employees
92

Comparables

Valuation

Metric
NIOX
SWAV
DWF
Price/Earnings (Normalized)
18.1878.218.98
Price/Book Value
4.2916.707.24
Price/Sales
8.2516.280.85
Price/Cash Flow
24.8952.566.01
Price/Earnings
NIOX
SWAV
DWF

Financial Strength

Metric
NIOX
SWAV
DWF
Quick Ratio
3.9912.491.78
Current Ratio
4.6513.811.93
Interest Coverage
34.0019.593.39
Quick Ratio
NIOX
SWAV
DWF

Profitability

Metric
NIOX
SWAV
DWF
Return on Assets (Normalized)
18.37%18.92%9.44%
Return on Equity (Normalized)
24.61%36.87%73.80%
Return on Invested Capital (Normalized)
20.31%20.45%15.38%
Return on Assets
NIOX
SWAV
DWF
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
BpzntzlgJwqjyx$180.4 Bil
Stryker Corp
SYK
BbghywnprfPvpv$131.4 Bil
Boston Scientific Corp
BSX
TpgmmzkXybcyz$112.9 Bil
Medtronic PLC
MDT
ZpsmnhsyRckqpvr$106.3 Bil
Edwards Lifesciences Corp
EW
JwtmhzcfkVhmngr$52.6 Bil
DexCom Inc
DXCM
LbqvylnpdSrvgz$45.9 Bil
Koninklijke Philips NV ADR
PHG
JngpsygbCrdkzyz$24.3 Bil
Zimmer Biomet Holdings Inc
ZBH
SvvfbrzprYrql$22.1 Bil
Steris PLC
STE
BcxkckbzLtgfgkv$21.6 Bil
Align Technology Inc
ALGN
DslzvjsPyrtx$19.3 Bil

Sponsor Center